Multiple sclerosis (MS) is a neurologic disorder of chronic inflammation and demyelination of the central nervous system. Several additional agents, including oral products, are now under investigation for the future treatment of MS.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Disease-modifying therapies for multiple sclerosis: Focus on future direction

Newsletter